| Literature DB >> 32572383 |
Tran Thi Ai My1, Huynh Thi Phuong Loan1, Nguyen Thi Thanh Hai1, Le Trung Hieu1, Tran Thai Hoa1, Bui Thi Phuong Thuy2, Duong Tuan Quang3, Nguyen Thanh Triet4, Tran Thi Van Anh5, Nguyen Thi Xuan Dieu5, Nguyen Tien Trung6, Nguyen Van Hue7, Pham Van Tat8, Vo Thanh Tung9, Nguyen Thi Ai Nhung1.
Abstract
GC-MS was applied to identify 24 main substances in Melaleuca cajuputi essential oil (TA) extracted from fresh cajeput leaves through steam distilling. The inhibitory capability of active compounds in the TA from Thua Thien Hue, Vietnam over the Angiotensin-Converting Enzyme 2 (ACE2) protein in human body - the host receptor for SARS-CoV-2 and the main protease (PDB6LU7) of the SARS-CoV-2 using docking simulation has been studied herein. The results indicate that the ACE2 and PDB6LU7 proteins were strongly inhibited by 10 out of 24 compounds accounting for 70.9% in the TA. The most powerful anticoronavirus activity is expressed in the order: Terpineol (TA2) ≈ Guaiol (TA5) ≈ Linalool (TA19) > Cineol (TA1) > β-Selinenol (TA3) > α-Eudesmol (TA4) > γ-Eudesmol (TA7). Interestingly, the synergistic interactions of these 10 substances of the TA exhibit excellent inhibition into the ACE2 and PDB6LU7 proteins. The docking results orient that the natural Melaleuca cajuputi essential oil is considered as a valuable resource for preventing SARS-CoV-2 invasion into human body.Entities:
Keywords: ACE2; Biological activity; Computational Chemistry; Melaleuca cajuputi oil; PDB6LU7; SARS-CoV-2
Year: 2020 PMID: 32572383 PMCID: PMC7300966 DOI: 10.1002/slct.202000822
Source DB: PubMed Journal: ChemistrySelect ISSN: 2365-6549 Impact factor: 2.109
Figure 1Picture of Melaleuca cajuputi leaves.
Identification of some bioactive compounds in Melaleuca cajuputi essential oil.
|
No. |
Compound |
Formula |
Structure |
Symbol |
Percentage (%) |
|---|---|---|---|---|---|
|
1 |
Cineol |
C10H18O |
|
|
31.6 |
|
2 |
Terpineol |
C10H18O |
|
|
10.7 |
|
3 |
β‐Selinenol |
C15H26O |
|
|
6.8 |
|
4 |
α‐Eudesmol |
C15H26O |
|
|
6.7 |
|
5 |
Guaiol |
C15H26O |
|
|
6.5 |
|
6 |
γ‐Eudesmol |
C15H26O |
|
|
4.3 |
|
7 |
Bulnesol |
C15H26O |
|
|
1.9 |
|
8 |
β‐Myrcene |
C10H16 |
|
|
0.9 |
|
9 |
Terpinen‐4‐ol |
C10H18O |
|
|
0.9 |
|
10 |
Linalool |
C10H18O |
|
|
0.6 |
Figure 3Native human angiotensin converting enzyme 2 (ACE2) protein docked with Cineol (TA1), β‐Selinenol (TA3), α‐Eudesmol (TA4), and γ‐Eudesmol (TA7) in the range of TA1 >TA3 > TA4 > TA7; (A) ACE2 crystal structure. Docking simulation with the interaction between compounds (B) TA1, (C) TA3, (D) TA4, (E) TA7 and ACE2 protein in human body.
Figure 4PDB6LU7 protein of the SARS‐CoV‐2 docked with Cineol (TA1), β‐Selinenol (TA3), α‐Eudesmol (TA4), and γ‐Eudesmol (TA7) in the range of TA1 > TA3 > TA4 > TA7; (A) Crystal structure of the SARS‐CoV‐2 main protease in complex (PDB6LU7). Docking simulation with the interaction between compounds (B) TA1, (C) TA3, (D) TA4, (E) TA7 and PDB6LU7 protein of SARS‐CoV‐2.
Docking simulation results with docking score energy (DS) and root mean square deviation (RMSD) between the most active compounds (TA2, TA5, TA19) in the Melaleuca cajuputi oil and the ACE2 and PBD6LU7 proteins.
|
Compound |
Symbol compound‐protein |
DS (kcal⋅mol−1) |
RMSD (Å) |
Interaction with amino acid |
|---|---|---|---|---|
|
Terpineol (TA2) |
TA2‐ACE2 |
‐11.0 |
1.97 |
Asn 103 (2.25 Å), Gln 101 (2.08 Å), His 195, Gln 102, Gln 81, Ala 193, Tyr 196 |
|
TA2‐SARS‐CoV‐2 |
‐10.9 |
1.16 |
His 163 (2.38 Å), Leu 41, Met 165, Phe 140, Glu 166, His 164, Asn 142, Ser 144, Cys 145, Gly 143, His 41 | |
|
Guaiol (TA5) |
TA5‐ACE2 |
‐11.1 |
1.49 |
Asn 103 (2.22 Å), Gln 101 (1.80 Å), Leu 85, Án 194, His 195, Tyr 196, Gln 102 |
|
TA5‐SARS‐CoV‐2 |
‐10.9 |
0.84 |
His 163 (2.51 Å), Glu 166, His 164, Met 165, Met 40, Gln 189, His 41, Leu 141, Ser144, Asn 142, Phe 140, Cys 145, His 122 | |
|
Linalool (TA19) |
TA19‐ACE2 |
‐10.9 |
1.77 |
Asn 210 ( 1.96 Å), Gln 98, Lys 562, Asp 206, Ala 396, Trp 566, Glu 208, Glu 564, Pro 565, Leu 95, Val 209, Leu 91, Lys 94 |
|
TA19‐SARS‐CoV‐2 |
‐11.1 |
1.18 |
Gly 143 ( 2.89 Å); Cys 145 (2.82 Å), Ser 144, Asn 142, Leu 141, Leu 27, Phe 140, His 41, Glu 166, His 163, Et 165, His 164 |
Docking simulation results with docking score energy (DS) and root mean square deviation (RMSD) between the most active compounds (TA1, TA3, TA4, TA7) in the Melaleuca cajuputi essential oil and the proteins (ACE2 and PBD6LU7).
|
Compound |
Symbol compound‐protein |
DS (kcal⋅mol−1) |
RMSD (Å) |
Interaction with amino acid |
|---|---|---|---|---|
|
Cineol ( |
|
‐10.8 |
1.28 |
Tyr 196 (2.32 Å), Gln 102, Gln 98, Asn 194, His 195, Gln 101 |
|
|
‐10.9 |
1.00 |
Glu 143 (2.31 Å), Asn 142, Leu 142, Thr 26, His 41, Met 49, His 164, Cys 145 | |
|
β‐Selinenol ( |
|
‐10.1 |
1.80 |
Tyr 202 (2.15 Å), Gly 205, Asp 206, Lys 562, Leu 95, Ala 99, Gln 98, Gln 102, Tyr 196, Trp 203 |
|
|
‐10.8 |
2.89 |
Leu 141 (1.97 Å), His 163, His 164, Glu 166, Gln 189, His 172, His 41, Met 49, Cys 145, Met 165, Gly 142, Ser 144, Phe 140, Asn 142 | |
|
α‐Eudesmol ( |
|
‐9.9 |
1.96 |
Asp 208 ( 2.83 Å), Trp 565, Ala 95, Val 289, Gln 102, Trp 203, Ala 396, Pro 565, Lys 562, Tyr 202. |
|
|
‐9.4 |
2.18 |
His 163 ( 2.23 Å), Phe 140, Glu 166, His 172, His 164, Ser 144, Asn 142, Cys 145, Met 165, Gly 143, Gln 189, His 41, Met 49, Leu 141, Phe 140. | |
|
γ‐Eudesmol ( |
|
‐9.9 |
1.21 |
Glu 208 (2.37 Å), Trp 566, Pro 565, Lys 562, Glu 564, Gln 98, Leu 95, Gln 102, Asp 206, Gly 205, Ala 396, Val 209. |
|
|
‐9.4 |
1.15 |
Leu 141 (1.90 Å), His 164, Glu 166, His 163, Met 165, Ser 144, Phe 140, Asn 142, Gln 189, Cys 145. |
Figure 2Terpineol (TA2), Guaiol (TA5), and Linalool (TA19) docked with ACE2 and PDB6LU7 proteins in the range of TA2 ≈ TA5 ≈ TA19; (A) Native human angiotensin converting enzyme 2 (ACE2) crystal structure. Docking simulation with the interaction between compounds (B) TA2, (C) TA5, (D) TA19 and ACE2 protein in human body; (E) Crystal structure of the SARS‐CoV‐2 main protease in complex (PDB6LU7). Docking simulation with the interaction between compounds (F) TA2, (G) TA5, (H) TA19 and PDB6LU7 protein of SARS‐CoV‐2.
Figure 53D‐docking simulation of the interactions between the 10 most active compounds (10TA): TA1, TA2, TA3, TA4, TA5, TA7, TA10, TA17, TA18, TA19 and (A) ACE2 protein including 12 interactions and (B) PDB6LU7 protein of the SARS‐CoV‐2 including 13 interactions.